- NSE
- LUPIN
- BSE
- 500257
- ISIN
- INE326A01037
LUPIN
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,015.00
−₹8.40 (−0.42%)
NSE close ·
LUPIN closed at ₹2,015.00 on 12 Nov 2026, down 0.42% on the day, and is down 0.93% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹1,922.00 to ₹2,514.80.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹92,145 Cr
- P/E (TTM)
- 17.7
- Industry P/E
- 35.0
- EPS (TTM)
- ₹113.59
- P/B
- 3.83
- Book value
- ₹525.93
- ROE
- 21.6%
- ROCE
- 25.4%
- Debt/equity
- 0.23
- Operating margin
- 22.7%
- Net margin
- 16.9%
- Dividend yield
- 0.89%
Market cap, P/E, P/B and yield at the 12 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +24.88% | +18.63% |
| Net profit | +20.10% | +57.02% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹7,954 Cr | ₹1,155 Cr | −22.19% | ₹25.14 |
| Jun 2026 | ₹8,407 Cr | ₹1,417 Cr | +16.01% | ₹30.89 |
| Mar 2026 | ₹7,615 Cr | ₹1,469 Cr | +87.72% | ₹31.89 |
| Dec 2025 | ₹7,282 Cr | ₹1,181 Cr | +37.45% | ₹25.67 |
| Sep 2025 | ₹7,138 Cr | ₹1,485 Cr | +72.76% | ₹32.28 |
| Jun 2025 | ₹6,347 Cr | ₹1,221 Cr | +51.63% | ₹26.62 |
| Mar 2025 | ₹5,724 Cr | ₹782 Cr | +112.48% | ₹16.87 |
| Dec 2024 | ₹5,821 Cr | ₹859 Cr | +38.82% | ₹18.69 |
Armor risk check
LUPIN moves about 1.3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is LUPIN's share price today?
LUPIN (NSE: LUPIN) closed at ₹2,015.00 on 12 Nov 2026, down 0.42% from the previous close of ₹2,023.40. It traded between ₹2,006.00 and ₹2,030.90 that day.
What are LUPIN's 52-week high and low?
Over the last 52 weeks LUPIN traded between ₹1,892.90 and ₹2,529.50, adjusted for splits and bonuses.
What are LUPIN's NSE symbol, BSE code and ISIN?
LUPIN has NSE symbol LUPIN, BSE code 500257, ISIN INE326A01037.
How has LUPIN performed over 1, 3 and 5 years?
LUPIN's share price return: 1Y −0.93%, 3Y +19.52% a year, 5Y +16.27% a year. Dividends are not included.
Does LUPIN pay a dividend?
Yes. LUPIN's latest dividend went ex on 17 Jul 2026: Final · ₹18.00 per share. Dividends over the past year come to a yield of 0.89% at the latest close.
What is LUPIN's P/E ratio?
LUPIN's P/E ratio is 17.7: the ₹2,015.00 close on 12 Nov 2026 over trailing twelve-month EPS of ₹113.59 (consolidated, four quarters to 30 Sep 2026).
What is LUPIN's market cap?
LUPIN's market cap is ₹92,145 Cr at the close on 12 Nov 2026.
Which sector is LUPIN in?
LUPIN is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how LUPIN fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app